Lung lipid metabolism participates both in infant and adult pulmonary disease. The lung is
composed by multiple cell types with specialized functions and coordinately acting to meet …

Idiopathic pulmonary fibrosis (IPF) is an incurable complex genetic disorder that is
associated with sequence changes in 7 genes (MUC5B, TERT, TERC, RTEL1, PARN …

Drug‐induced toxicity is a key issue for public health because some side effects can be
severe and life‐threatening. These adverse effects can also be a major concern for the …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by
progressive loss of pulmonary function. Drug-induced interstitial lung disease has been …

Many lung diseases result in fibrotic remodelling. Fibrotic lung disorders can be divided into
diseases with known and unknown aetiology. Among those with unknown aetiology …

Pulmonary fibrosis can develop in association with genetic variants, occupational and
environmental exposures, adverse reactions to numerous medications, and many …

Blockchain, which has a distributed structure, has been widely used in many areas.
Especially in the area of smart cities, blockchain technology shows great potential. The …

The lungs are exposed to a range of environmental toxins (including cigarette smoke, air
pollution, asbestos) and pathogens (bacterial, viral and fungal), and most respiratory …

Exposure to inhaled pollutants, including fine particulates and cigarette smoke is a major
cause of lung disease in Europe. While it is established that inhaled pollutants have …

Idiopathic pulmonary fibrosis (IPF) is age-related interstitial lung disease of unknown
etiology. About 100,000 people in the US have IPF, with a 3-year median life expectancy …